Impact of injecting drug use on the interruption of antiretroviral therapies
Table 1
Bibliographic Data
| ID | 11175993 |
|---|---|
| Authors | Roberto Muga (0000-0001-6301-431X, Hospital Universitari Germans Trias i Pujol, corresponding author), J M Egea (Hospital Universitari Germans Trias i Pujol), A Sanvisens (Hospital Universitari Germans Trias i Pujol), J Arnal (Hospital Universitari Germans Trias i Pujol), C Tural (Hospital Universitari Germans Trias i Pujol), J Tor (Hospital Universitari Germans Trias i Pujol), C Rey-Joly (Hospital Universitari Germans Trias i Pujol) |
| Year | 2004 |
| Volume | 58 |
| Issue | 4 |
| Pages | 286-287 |
| Publication date | 2004-04-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Epidemiology and Community Health (JOURNAL) |
| Journal identifiers | ISSN: 0143-005X • E-ISSN: 1470-2738 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/jech.2003.010066 |
| PMID | 15026439 |
| OpenAlex | W1975439177 |
| Language | EN |
| Citations received | 2 |
| References cited | 2 |
It has been pointed out that HIV positive patients with a history of drug misuse are less likely to undergo antiretroviral therapy (ART) than those who belong to other categories of transmission.1,2 Moreover, inadequate use of ART in injecting drug users (IDUs) is controversial because of the risk of parenteral and/or sexual transmission of drug resistant HIV variants.3 The aim of this study was to describe the frequency of use and cessation of antiretroviral regimens over a period characterised by the introduction of highly active antiretroviral therapy (HAART) in Spain. ### Patients Cross sectional study in HIV positive intravenous heroin misusers consecutively referred to detoxification in a tertiary hospital in metropolitan Barcelona between April 1997 and March 2000. Questionnaires on the characteristics of injecting drug use
Antiretroviral therapy · Drug · Human immunodeficiency virus (HIV) · Intensive care medicine · Viral load · HIV Research and Treatment · HIV, Drug Use, Sexual Risk · HIV/AIDS drug development and treatment · Medicine · Pharmacology · Virology
| Citations per year | 2 |
|---|---|
| Citation span | 2025 - 2026 (2) |
| Highly cited | No |